0001209191-19-008930.txt : 20190211 0001209191-19-008930.hdr.sgml : 20190211 20190211162215 ACCESSION NUMBER: 0001209191-19-008930 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190207 FILED AS OF DATE: 20190211 DATE AS OF CHANGE: 20190211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VANDERTIE MICHELLE L CENTRAL INDEX KEY: 0001701690 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36003 FILM NUMBER: 19585755 MAIL ADDRESS: STREET 1: C/O CONATUS PHARMACEUTICALS INC. STREET 2: 16745 WEST BERNARDO DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92127 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Conatus Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001383701 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 203183915 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 16745 WEST BERNARDO DRIVE STREET 2: Suite 200 CITY: San Diego STATE: CA ZIP: 92127 BUSINESS PHONE: (858) 376-2600 MAIL ADDRESS: STREET 1: 16745 WEST BERNARDO DRIVE STREET 2: Suite 200 CITY: San Diego STATE: CA ZIP: 92127 FORMER COMPANY: FORMER CONFORMED NAME: Conatus Pharmaceuticals Inc DATE OF NAME CHANGE: 20061214 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-07 0 0001383701 Conatus Pharmaceuticals Inc. CNAT 0001701690 VANDERTIE MICHELLE L C/O CONATUS PHARMACEUTICALS INC. 16745 W. BERNARDO DRIVE, SUITE 200 SAN DIEGO CA 92127 0 1 0 0 Vice President, Finance Stock Option (Right to Buy) 2.00 2019-02-07 4 A 0 50000 0.00 A 2029-02-06 Common Stock 50000 50000 D The option was granted on February 7, 2019. 25% of the total number of shares of common stock subject to the option will vest on February 6, 2020, and 1/48th of the total number of shares of common stock subject to the option will vest monthly thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. /s/ Michelle L. Vandertie 2019-02-11